Line 21: |
Line 21: |
| | | |
| | | |
− | '''First Generation Cephalosporins''' - Cefalexin, Cefalonium | + | '''First Generation Cephalosporins''' - Cefalexin, Cefalonium, Cephapirin |
| * Active against gram positive organisms | | * Active against gram positive organisms |
| * Active aginst many gram negatives. ''Pseudomonas'' species are resistant. | | * Active aginst many gram negatives. ''Pseudomonas'' species are resistant. |
| | | |
− | '''Second Generation Cephalosporins''' - Ceftiofur | + | '''Second Generation Cephalosporins''' - Cefuroxime |
| * Very broad spectrum with very high activity against enterobacteriaeceae. | | * Very broad spectrum with very high activity against enterobacteriaeceae. |
| * Struggle against the most difficult gram negative organisms | | * Struggle against the most difficult gram negative organisms |
| | | |
− | '''Third Generation Cephalosporins''' - Cefoperazone | + | '''Third Generation Cephalosporins''' - Cefoperazone, Ceftiofur |
| * Very active against gram negatives, especially the hardier species, including ''Pseudomonas'' | | * Very active against gram negatives, especially the hardier species, including ''Pseudomonas'' |
| * Less active against gram positives compared to other cephalosporins; Staphylococci and enterococci can be resistant. | | * Less active against gram positives compared to other cephalosporins; Staphylococci and enterococci can be resistant. |
| | | |
| '''Fourth Generation Cephalosporins''' - Cefquinome | | '''Fourth Generation Cephalosporins''' - Cefquinome |
− | * Very broad spectrum, only the very hardiest of gram negatives aren't susceptible. It is still active againts ''Pseudomonas''. | + | * Very broad spectrum, only the very hardiest of gram negatives aren't susceptible. It is still active against ''Pseudomonas''. |
− | | |
| | | |
| ==Pharmacokinetic Considerations== | | ==Pharmacokinetic Considerations== |
Line 52: |
Line 51: |
| * Very high doses has been known to result in nephrotoxicity. | | * Very high doses has been known to result in nephrotoxicity. |
| * They can result in bleeding problems because of interference with the formation of vitamin K in the gut (esp Moxalactam). | | * They can result in bleeding problems because of interference with the formation of vitamin K in the gut (esp Moxalactam). |
| + | |
| + | {{Learning |
| + | |Vetstream = [https://www.vetstream.com/equis/Content/Freeform/fre00352.asp Beta-Lactam Antibacterials]}} |